IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

CPhI: Actavis Expands into New Markets, Will Enter Biosimilars

3:18 AM MDT | October 21, 2009 | Deepti Ramesh in Madrid

Generic pharmaceuticals manufacturer Actavis (Hafnarfjordur, Iceland) says the company is in the process of expanding its presence in regions such as Japan, Mideast and South America, and it also closely monitors the biosimilar market and related activities within the business sector. Actavis says that biosimilars will play a major role in the generics industry in the future. Biosimilars are approved versions of innovator biopharmaceutical products introduced after patent expiry. A recent report by research and consulting firm Markets and Markets (Wilmington, DE)...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa